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Estrogen-related receptors (ERRs) play critical roles in regulation of cellular energy metabolism in response
to inducible coactivators such as peroxisome proliferator-activated receptor gamma (PPAR) coactivator 1
(PGC-1). A yeast two-hybrid screen led to the identification of the cytokine-stimulated transcriptional
regulator, Bcl3, as an ERR coactivator. Bcl3 was shown to synergize with PGC-1 to coactivate ERR.
Chromatin immunoprecipitation studies demonstrated that ERR, PGC-1, and Bcl3 form a complex on an
ERR-responsive element within the pyruvate dehydrogenase kinase 4 gene promoter in cardiac myocytes.
Mapping studies demonstrated that Bc13 interacts with PGC-1 and ERR, allowing for interaction with both
proteins. Transcriptional profiling demonstrated that Bcl3 activates genes involved in diverse pathways
including a subset involved in cellular energy metabolism known to be regulated by PGC-1, ERR, and a
second nuclear receptor, PPAR. Consistent with the gene expression profiling results, Bcl3 was shown to
synergistically coactivate PPAR with PGC-1 in a manner similar to ERR. We propose that the cooperat-
ivity between Bcl3 and PGC-1 may serve as a point of convergence on nuclear receptor targets to direct
programs orchestrating inflammatory and energy metabolism responses in heart and other tissues.
The nuclear receptor superfamily of transcription factors
regulate the expression of genes involved in multiple cellular
processes including metabolism, growth, differentiation, and
inflammation (6, 14, 42). Canonical nuclear receptors are ac-
tivated by small-molecule ligands which alter the structural
conformation of the receptors, leading to recruitment of coac-
tivator complexes that confer chromatin remodeling and pro-
mote assembly of the RNA polymerase II machinery on target
gene promoters (36). The natural ligands for many nuclear
receptors have been identified, providing a basis for subclassi-
fication of the superfamily (7). Nuclear receptor ligands can be
classic hormones, such as for the thyroid and glucocorticoid
receptors, or intermediary metabolites (e.g., liver X receptor
and peroxisome proliferator-activated receptor [PPAR]).
The activating ligands for a subset of nuclear receptors,
termed orphan receptors, have not been defined (7). Evidence
is emerging that some members of this subgroup of nuclear
receptors may not require ligand activation but, rather, are
subject to control by specific corepressors and coactivators,
depending on cell type and physiological context. The estro-
gen-related receptor , or ERR, one of the first orphan
receptors to be cloned, is a member of this latter category (18).
ERR can activate or repress genes depending on cell type
and promoter context. Recent studies have begun to define
relevant ERR coactivators and corepressors (18). The
PPAR coactivator 1 (PGC-1) has been shown to serve an
essential role as an ERR coactivator (27, 30, 47). PGC-1 is
expressed in a tissue-specific manner, with highest expression
in tissues with high energy demands such as heart, and its
expression is induced by various physiological stimuli (22, 27,
45). PGC-1/ERR targets include a wide array of genes in-
volved in cellular energy metabolism including most mitochon-
drial energy transduction and ATP production pathways (13,
29). Whereas the role of PGC-1 coactivators in the control of
ERR activity is well established, it is likely that other regu-
latory factors participate in the physiological regulation of
ERR signaling.
Nuclear receptors direct gene-regulatory events involved in
diverse biological processes including development, metabo-
lism, and physiological responses. Accordingly, it is possible
that this group of transcription factors, and their respective
coregulators, serve as nodal points for cross talk with other
cellular signaling pathways. Indeed, recent studies have pro-
vided evidence for this notion, showing that the nuclear recep-
tor PPAR is capable of exerting repressive effects on cyto-
kine-triggered gene-regulatory events in macrophages by
interacting with corepressors in a sumoylation-dependent
manner (43). Other investigators have proposed mechanisms
whereby cytokines converge on metabolism, energetics, and
host immune response through ERR, PGC-1, and PGC-1
(44, 49, 53). These findings strongly suggest that in addition to
directly regulating target genes, a subset of nuclear receptors
exerts regulatory cross talk upon other cellular signaling path-
ways.
In this study, we sought to identify novel nuclear receptor
coregulatory proteins. We were especially interested in the
PGC-1/ERR cascade, given its importance in controlling cel-
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lular energy metabolism pathways that are likely to respond to
other biological signaling cascades. To this end, yeast two-
hybrid screening studies were conducted to identify new ERR
coregulators. This screen identified the IB family of proteins
as potential interacting partners of ERR in the cardiac myo-
cyte. We found that one of the IB family members, Bcl3,
functions synergistically with PGC-1 to coactivate the nuclear
receptors ERR and PPAR in cardiac myocytes. The Bcl3-
interacting domains within PGC-1 and ERR are distinct,
allowing for the formation of a multiprotein complex on target
promoters. These results identify a nodal point for the conver-
gence of inflammatory stress response signals and nuclear re-
ceptor-mediated regulation of genes involved in cellular en-
ergy metabolism.
MATERIALS AND METHODS
Yeast two-hybrid screen. The yeast two-hybrid screen was performed using a
Matchmaker Two-Hybrid System (Clontech) as per the manufacturer’s instruc-
tion. Briefly, human ERR cDNA corresponding to the ligand-binding domain
(amino acids 197 to 422) was cloned into pAS2-1 vector and cotransformed with
a human heart cDNA library (Clontech) into Saccharomyces cerevisiae strain
CG-1945. A total of 1.3 million transformants were screened, and after the false
positives were selected out using pAS2-1-lamin C as a negative control, 46
positive clones remained. Four of 46 were identified as IB.
Plasmid constructs. (i) Mammalian expression vectors. pcDNA3.1-myc/
his.PGC-1Wt (where PGC-1Wt is the full-length protein) has been previously
described (54) and was used as a template to PCR-amplify cDNA of PGC-1
consisting of residues 1 to 701 (PGC-1701) using the following primers: 5-AT
GGCTTGGGACATGTGCAG-3 and 5-TCATTCACCAAAAACTTCAAAG
C-3. The amplicon was subsequently cloned into pcDNA3.1-myc/his vector and
checked by sequencing. The human Bcl3 cDNA (a kind gift from U. Sibenlist)
was cloned into pcDNA3.1 vector (Invitrogen). Construction of expression
vectors consisting of pcDNA3.1 fused to full-length ERR (ERRWt,) and to
COOH-terminal deletion mutants (ERR403, ERR359, ERR144, consisting of
residues 1 to 403, 1 to 359, and 1 to 144, respectively), pEFBOS-PPAR,
pEFBOS-RXR, pCMX-Gal4, and pCMX-Gal4-ERR as well as the reporter
constructs Vit2P36.Luc (11), mPDK4.Luc.2281 (where mPKD4 is the mouse
pyruvate dehydrogenase kinase 4), NRptmutmPDK4.Luc.2281, (PPRE)X3TK.
Luc, and (UAS)X3TK.Luc (where PPRE is peroxisome proliferator response
element, TK is thymidine kinase, and UAS is upstream activation sequence) have
been previously described (27, 46, 54, 56).
(ii) Bacterial expression vectors. pGEX4T-3-ERRWt has been described
previously (27). pGEX4T-1-PPAR and pGEX4T-1-Bcl3 were made by cloning
human cDNA for PPAR and Bcl3 into pGEX4T-1 (GE Healthcare), respec-
tively.
(iii) Adenoviral expression vectors. AdBcl3 was generated by cloning human
Bcl3 cDNA into the AdTrack-CMV vector and recombined with pAd-Easy as
previously described (24).
Mammalian cell culture, transient transfection, and luciferase reporter stud-
ies. CV-1, COS7, and HEK 293 cells were cultured at 37°C and 5% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum.
Transient transfections were performed using FuGENE6 (Roche) as per the
manufacturer’s protocol. Briefly, 100 ng of reporter was cotransfected with 10 ng
of expression vectors for nuclear receptors, 50 ng of expression vectors for
nuclear receptor coactivators, and 10 ng of simian virus 40 promoter-driven
Renilla luciferase to control for transfection efficiency. All cell culture wells were
balanced for equal amounts of expression vector backbones. For luciferase re-
porter assays, cells were collected 36 to 48 h after cotransfection and analyzed
using Dual-Glo (Promega) as per the manufacturer’s protocol. Ventricular car-
diac myocytes were prepared from 1-day-old Harlan-Sprague-Dawley rats as
previously described (12). After 24 h in culture, cells were infected with adeno-
virus expressing green fluorescent protein (AdGFP) or GFP and Bcl3 (AdBcl3).
An infection rate of 95% was achieved at 72 h postinfection. Subsequently, cells
were collected for RNA isolation.
GST pulldown assays. The glutathione S-transferase (GST) protein-protein
interaction assay has been previously described (54). Briefly, all 35S-labeled
proteins were synthesized in a TNT Quick Coupled transcription/translation
system (Promega) as per the manufacturer’s protocol. All GST fusion proteins
were grown in BL21 competent bacterial cells (Stratagene) and purified on
GSH-Sepharose (GE Healthcare). In the pulldown reaction, 3 g of the fusion
protein was incubated with 10 l of 35S-labeled protein in 500 l of binding
buffer (20 mM Tris, pH 7.5, 100 mM KCl, 0.1m MEDTA, 0.05% Nonidet P-40,
10% glycerol, 1 mg/ml bovine serum albumin, 0.5 mM phenylmethylsulfonyl
fluoride [PMSF], and 1 Complete [Roche] with or without 5,8,11,14-eicosate
traynoic acid [ETYA; Calbiochem]). The reaction mixture was incubated at 4°C
for 2 h and then washed six to eight times with cold binding buffer. The fusion
proteins and their potential interacting partners were analyzed by sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Coimmunoprecipitation and immunoblotting studies. For coimmunoprecipi-
tation studies, COS7 cells were transfected with mammalian expression vectors
using FuGENE6 (Roche) per the manufacturer’s protocol. After 48 h, cells were
collected in lysis buffer (1 phosphate-buffered saline, 1 mM EDTA, 0.5%
TritonX-100, 1 Complete, 1 mM PMSF). Cells were lysed with a sonicator, and
1 g of M2 anti-FLAG (Sigma) or 9E10 anti-Myc (Santa Cruz) antibody was
added to the extract with protein G-Sepharose (Zymed) and incubated for 24 h
at 4°C. The Sepharose was washed three times with the lysis buffer, and the
immunoprecipitated proteins were analyzed by immunoblotting.
Immunoblotting was performed as previously described (28). Briefly, protein
extracts were resolved on SDS-PAGE gels and transferred onto nitrocellulose
membranes. Detection of ERR and PGC-1 was performed using antibodies as
previously described (27, 32, 56). Detection of Bcl3 was performed using com-
mercially available antibodies (Santa Cruz).
ChIP assays. Chromatin-immunoprecipitation (ChIP) assays were performed
as previously described (56). Briefly, rat ventricular cardiac myocytes were cul-
tured for 72 h. Cells were cross-linked with 1% formaldehyde (10 min), followed
by the addition of 0.125 M glycine to halt the cross-linking. Cells were collected
and lysed in nuclear lysis buffer (50 mM Tris, pH 8.0, 10 mM EDTA, 1% SDS,
10 mM sodium butyrate, 300 M PMSF, and 1 Complete). Chromatin was
collected, sonicated, and incubated with immunoglobulin G (IgG) or with poly-
clonal antibodies against PGC-1 (32), ERR (56), or Bcl3 (Santa Cruz) at 4°C
for 2 h before protein A-Sepharose (Zymed) was added for an overnight incu-
bation. The Sepharose was washed and eluted, and the eluted chromatin was
analyzed by PCR using the following primers: ratPDK4P(f) (5-TGATTGGCT
ACTGTAAAAGTCCCG-3) and ratPDK4p(r) (5-GTCCCAGGTCGCCCGG
GGCTTCAGG-3), which correspond to 	462 to 	297 of the rat PDK4 pro-
moter; ratPDK4IC(f) (5-ACACTGTCTCCCTCTCCTC-3) and ratPDK4IC(r)
(5-TCCATGCTTGTGAGATTCTG-3), which correspond to 	1924 to 	2144
of the rat PDK4 promoter; and 36B4 primers which have been previously de-
scribed (56). Qualitative PCR was performed by amplifying the immunoprecipi-
tated chromatin with the primers described above under the following cycling
conditions: 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s for 26 cycles; the
reaction was analyed using 1% agarose gel electrophoresis. This experiment was
quantified using SYBR green real-time quantitative PCR (Applied Biosystem,
Foster City, CA). The PCR conditions used were the same as above except the
cycle number was increased to 40. For ChIP-reimmunoprecipitation studies, the
primary immunoprecipitation was performed using ERR antibody as described
above. The complexes were eluted in 10 mM dithiothreitol at 37°C for 30 min
and diluted 1:10 in immunoprecipitation buffer (48). All subsequent steps were
as described above.
siRNA studies. Adenovirus expressing small interfering RNA (siRNA) against
rat ERR (siERR) and its backbone control (Super) were generous gifts from
A. Kralli (25). Primary rat cardiac myocytes were infected with these viruses for
24 to 48 h at a multiplicity of infection of 50 prior to the harvesting of cells.
siRNAs against rat Bcl3 and the control were purchased from Ambion (control-
AM4611, Bcl3#1-s183606, Bcl3#2-s189734, and Bcl3#3-s183605). One micro-
gram of mPDK4.Luc.2281 with 5 picomoles of siRNA was transfected into
primary rat cardiac myocytes using the calcium phosphate coprecipitation
method (20).
Gene expression array analyses. Total RNA was isolated from rat neonatal
cardiac myocytes with RNAzol (Tel-Test Inc.) after adenoviral infection as
described above. cRNA was synthesized from total RNA as previously described
(29). The Alvin Siteman Cancer Center’s Multiplexed Gene Analysis Core at
Washington University School of Medicine performed the hybridization to the
Affymetrix rat U34A chip. Spotfire for Functional Genomics software was used
for the initial analysis and background normalization. Subsequent data analyses
were performed on Excel. Pathway analyses were performed on GenMAPP2 and
MAPPFinder2 software. Inclusion criteria for regulated genes are provided in
the footnote to Table 1.
qRT-PCR. Total RNA was isolated from rat neonatal cardiac myocytes after
adenoviral infection as described above, and real-time quantitative reverse tran-
scription-PCR was performed as previously described (29, 56). Primers for rat
fatty acid binding protein 3 (rFABP3) and rat very-low-density lipoprotein re-
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ceptor (rVLDLR) were as follows: rFABP3(f) (5-AAGCCCGGCTCACATTG
A-3) and rFABP3(r) (5-CCACTGAACTTTTCCATTGGT-3); rVLDLR(f)
(5-TCATCATCTGTGCTTACA-3) and rVLDLR(r) (5-ACTTACAGTGAG
ACAAAAG-3).
Statistical analyses. Transient transfection results were analyzed using one-
way analysis of variance with subsequent post hoc Tukey’s pairwise analyses. All
real-time quantitative PCR results were analyzed using a Student’s t test. The
statistical analyses for the gene chip studies were performed using Spotfire and
MAPPFinder2 software, which consist of Student’s t test and nonparametric
bootstrapping/Westfall-Young adjustment for multiple testing, respectively.
Data are presented as means 
 standard error of the mean (SEM), with statis-
tically significant differences as P value less than or equal to 0.05.
RESULTS
The IB family member Bcl3 interacts with and coactivates
the nuclear receptor ERR. A yeast two-hybrid screen was
conducted to identify proteins that interact with the ligand-
binding domain of ERR. Approximately 1.3 million indepen-
dent clones of a human heart cDNA library were screened,
resulting in isolation of 46 positive clones, 17 of which were
redundant clones of known ERR-interacting proteins (ERR
and SRC1) and 4 of which encoded the IB family member,
IB (see Table S1 in the supplemental material). The func-
tional significance of the potential interaction of IB with
ERR was assessed in cotransfection studies in which an
ERR-responsive luciferase reporter (Vit2P36.Luc) was trans-
fected into HEK 293 cells in the presence and absence of
expression vectors for IB. IB did not have any effect on
the ERR-mediated activation of Vit2P36.Luc; moreover, it
did not influence PGC-1-mediated coactivation of ERR
(Fig. 1A and data not shown). These results are consistent with
previous observations that IB is predominantly a cytoplas-
mic protein, whereas ERR is a transcription factor whose
intracellular localization is likely to be predominantly nuclear
although this has not been fully substantiated (21, 33). How-
ever, another member of the IB family, Bcl3 (Fig. 1B), which
shares homology with IB, is known to enter the nucleus and
can function as a transcriptional coactivator for other tran-
scription factors including NF-B (1, 15) and the nuclear re-
ceptor RXR (38). Accordingly, cotransfection experiments
were repeated to determine whether Bcl3 could interact with
ERR in a functionally relevant manner. Whereas neither
Bcl3 nor ERR alone had a significant activating effect on the
reporter, together they activated the reporter sixfold (Fig. 1A).
Similarly, Bcl3 and ERR synergistically activated a second
ERR-responsive reporter, mPDK4.Luc.2281 (56), which con-
tains the promoter of the ERR-responsive mouse PDK4
gene. This synergism was completely abolished when a single
point mutation was placed in the ERR-responsive element
within mPDK4.Luc.2281 (Fig. 1A). To explore the relevance of
the Bcl3-mediated transcriptional regulation of the ERR tar-
get PDK4, Bcl3 knockdown studies were conducted in primary
neonatal rat cardiac myocytes, which express Bcl3 (data not
shown). Three independent siRNAs against Bcl3 significantly
reduced basal mPDK4.Luc.2281 promoter activity by 30 to
40% (Fig. 1C).
To determine whether Bcl3 interacts directly with ERR, GST
pulldown assays were performed. Full-length ERR (ERRWt)
bound a GST-Bcl3 fusion protein (Fig. 2A). ERR COOH-ter-
minal deletion mutants (ERR403, ERR359, and ERR144)
were next assessed to map the Bcl3-interacting region. Bcl3
bound similarly to ERRWt and ERR403; however, only mini-
mal residual binding was observed with ERR359 (Fig. 2A). Bcl3
binding was completely abolished with ERR144. Taken together,
these results identify at least two Bcl3 interacting regions within
amino acids 359 to 403 and 144 to 359 of the ERR protein (Fig.
2A). These findings were surprising, given that all known coacti-
vator interacting sites in the ERR molecule involve the COOH-
terminal AF-2 domain (18). Consistent with the results of the
binding studies, Bcl3 coactivated both ERRWt and ERR403 but
not ERR359 in cell cotransfection studies (Fig. 2B).
Bcl3 synergizes with PGC-1 to coactivate ERR. To ex-
plore the possibility that Bcl3 influences the coregulation of
ERR by PGC-1, ERR reporter cotransfection experiments
were repeated in the absence and presence of PGC-1. Indi-
vidually, PGC-1 and Bcl3 modestly coactivated (three to sev-
enfold) ERR on either Vit2P36.Luc or mPDK4.Luc.2281
(Fig. 3). However, when added together, PGC-1 and Bcl3
mediated a marked (30-fold) synergistic coactivation of ERR
(Fig. 3). PGC-1 also modestly boosted the Bcl3-mediated
activation of mPDK4.Luc.2281 (Fig. 3), an effect likely medi-
ated through an endogenous transcription factor other than
ERR, given that ERR is not immunodetectable in this cell
line (data not shown). The synergism between PGC-1 and
Bcl3 was also seen in studies using the Gal4 hybrid system in
which a Gal4 DNA binding domain was fused to ERR (Gal4-
ERR). The (UAS)X3TK.Luc reporter, which contains three
copies of Gal4 binding elements, was repressed by Gal4-ERR
by approximately 80%. The addition of either PGC-1 or Bcl3
modestly activated Gal4-ERR, but together the proteins con-
ferred a ninefold activation (Fig. 3). These results strongly
suggest that Bcl3 and PGC-1 form a functionally cooperative
complex with ERR.
GST pull-down assays were performed to determine
whether, as suggested by the observed functional cooperativity,
PGC-1 and Bcl3 interact directly. Full-length PGC-1 pro-
tein (PGC-1Wt) bound to Bcl3 (Fig. 4A). Surprisingly, a C-
terminal deletion mutant (PGC-1701) was unable to bind to
Bcl3 (Fig. 4A). This latter result was surprising given that
previously identified protein-protein interaction domains
within the PGC-1 molecule do not involve this region. PGC-
1701 still retained its ability to bind to ERR, given that the
ERR-interacting domains are still present in this truncated
mutant (Fig. 4A) (27). The functional significance of the PGC-
1–Bcl3 interaction was tested in cotransfection experiments
using Vit2P36.Luc and mPDK4.Luc.2281. PGC-1Wt and Bcl3
coactivated ERR on the two reporters 60-fold and 45-fold,
respectively. In contrast, activation by PGC-1701 and Bcl3 was
only 20-fold and 15-fold, respectively (additive rather than
synergistic) (Fig. 4B). These results indicate that PGC-1 and
Bcl3 interact directly through a novel protein interaction do-
main within the COOH-terminal 96 amino acids of the
PGC-1 protein.
We next sought to determine whether ERR, PGC-1, and
Bcl3 form a complex in cells. To address this, coimmunopre-
cipitation experiments were conducted in COS7 cells over-
expressing Flag epitope-tagged ERR (Flag-ERR), myc
epitope-tagged PGC-1 (PGC-1-myc), and Bcl3 to assess a
combination of two-way interactions. As expected, PGC-1 or
Bcl3 was individually immunoprecipitated with ERR (Fig. 5A
and B). Importantly, when all three proteins were over-
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expressed, anti-Flag antibody coimmunoprecipitated both
PGC-1 and Bcl3 along with ERR (Fig. 5A and B). Interest-
ingly, only the dephosphorylated form of Bcl3 (the nuclear-
localized form) (3, 4, 40) coimmunoprecipitated with ERR
(Fig. 5A and B). We also noted that the level of coimmuno-
precipitation between Flag-ERR and one coactivator was not
perturbed by the presence of the other coactivator (Fig. 5A
and B). Immunoprecipitation of PGC-1-myc also pulled out
ERR. However, in this latter experiment, the amount of
ERR coimmunoprecipitated with PGC-1 was reduced by
FIG. 1. (A) Bc13, but not IB, coactivates ERR. (Top) A schematic representation of Vit2P36.Luc heterologous promoter-luciferase
reporter construct with two copies of the estrogen receptor response element (ERE) derived from the vitellogenin promoter linked to prolactin
promoter (prl) and luciferase (Luc) reporter. This reporter was cotransfected into HEK 293 cells with combinations of ERR, IB, and Bcl3 as
indicated below the graph. (Bottom) Schematic representations of mPDK4.Luc.2281 and NRptmutmPDK4.Luc.2281 homologous promoter-
reporter constructs containing the ERR response element or its nuclear receptor point mutant equivalent within the 	2281 to 31 region of the
mouse PDK4 promoter linked to luciferase. These reporters were cotransfected into CV-1 cells with combinations of ERR and Bcl3 as indicated.
The bars represent mean (
 SEM) relative light units (RLU) corrected for Renilla luciferase activity, a measure of transfection efficiency, and
normalized to basal Vit2P36.Luc, mPDK4.Luc.2281, or NRptmut mPDK4.Luc.2281 activity (set at 1.0). All values represent the results of a
minimum of three independent transfections conducted in triplicate. , significant difference compared to reporter activity with ERR alone (P 
0.05); N.S., not significant. (B) Schematic representation of IB and Bcl3 proteins. The numbers represent amino acids, and gray boxes denote
individual ankyrin repeat domains. (C) Endogenous Bcl3 activates the mPDK4.Luc.2281 reporter in primary rat cardiac myocytes. The
mPDK4.Luc.2281 reporter was transfected into primary rat cardiac myocytes with either control siRNA or three independent siRNAs directed
against Bcl3. The bars represent mean (
 SEM) relative light units (RLU) corrected for Renilla luciferase activity and normalized to basal
mPDK4.Luc.2281 reporter and siRNA control (set at 1.0). All values represent the results of two independent transfections conducted in triplicate.
, significant difference compared to reporter plus control siRNA (P  0.05).
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the presence of Bcl3 (Fig. 5C), suggesting that Bcl3 interfered
with the PGC-1-myc/-myc interaction.
To determine whether endogenous ERR serves as a plat-
form for the assembly of Bcl3 and PGC-1 on target gene
promoters, ChIP experiments were performed using the PDK4
gene promoter. Primary rat cardiac myocytes were chosen for
these experiments because PDK4 levels are relatively high in
this cell type (2). Immunoprecipitation with antibodies to
ERR, PGC-1, or Bcl3 resulted in significant enrichment of
the relevant ERR response region within the PDK4 promoter
region. To establish that both coactivators occupied this region
with ERR, chromatin immunoprecipitated with antibody
FIG. 2. Bcl3 interacts with ERR. (A) Schematic representations of ERR and its truncation mutants used in GST pulldowns to localize the
ERR interaction with Bcl3. The gray regions represent the major domains: the DNA binding domain (DBD) and the ligand binding domain
(LBD) with the numbers corresponding to amino acid positions. Bacterially expressed GST or GST-Bcl3 fusion proteins were used with 35S-labeled
full-length or truncated mutants of ERR in GST pulldown assays. Twenty percent of the radiolabeled proteins used in the binding reaction (20%
Input) and GST fusion proteins with their potential binding partners were analyzed by SDS-PAGE (proteins are indicated by their subscripts).The
result shown is representative of three independent experiments. (B) Transient transfection experiments using mPDK4.Luc.2281 reporter was
performed in CV-1 cells with either no nuclear receptor, ERR, or its truncation mutants (ERR403 and ERR359) and cotransfected with empty
vector (white bars) or Bcl3 (black bars). The bars represent mean (
 SEM) relative light units (RLU) corrected for Renilla luciferase activity and
normalized to basal mPDK4.Luc.2281 activity (set at 1.0). All values represent the results of three independent transfections conducted in
triplicate. , significant difference (P  0.05) between bracketed values; N.S., not significant.
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against ERR was reimmunoprecipitated with antibodies
against PGC-1 or Bcl3, resulting in reenrichment of the
ERR response region (Fig. 5D). Moreover, when this ChIP
experiment was conducted in the presence of an adenovirus
expressing siERR, enrichment of the ERR response region
by antibodies against either PGC-1 or Bcl3 was abolished
(Fig. 5E). Taking the cotransfection and immunoprecipitation
results together, we conclude that PGC-1 and Bcl3 interact
cooperatively in a complex with ERR to activate the tran-
scription of at least a subset of ERR target genes.
Bcl3 activates cardiac myocyte genes involved in cellular
metabolism and additional biological pathways. To identify
potential target genes of Bcl3 in cardiac myocytes, a recombi-
nant adenovirus expressing Bcl3 was used to infect rat neonatal
cardiac myocytes with consequential gene expression profiling.
A total of 496 upregulated genes and 17 downregulated genes
met inclusion criteria in our initial analysis (Table 1; see also
Tables S2 and S3 in the supplemental material). The gene
expression changes clustered around a subset of biological
processes defined by 266 pathways identified using an unbiased
pathway analytic tool (Table 1) (see Materials and Methods).
A predominance of pathways involved in cellular fuel and
mitochondrial energy metabolism were upregulated by Bcl3,
including fatty acid oxidation, oxidation phosphorylation, and
glucose metabolism (Table 1; see also Tables S2 and S3 in the
supplemental material). Notably, ERR and PGC-1 have
been established as important regulators of many genes in
these pathways, and several of the genes identified in this
analysis are known ERR target genes (13, 27, 29). Further
validation of these results was provided by qRT-PCR studies
demonstrating that mitochondrial fatty acid oxidation
(MCAD), PDK4 (negative regulator of glucose oxidation),
FABP3, and VLDLR mRNA levels were significantly upregu-
lated by Bcl3 in cardiac myoctyes (Fig. 6; see also Tables S2
and S3 in the supplemental material). These results strongly
suggest that Bcl3 serves as a bona fide coregulator of metabolic
pathways downstream of PGC-1/ERR. In addition to energy
metabolism, target genes involved in several other biological
processes, including cell cycle control, the immune response,
peptidase activity, cell adhesion, ubiquitination, vascular de-
velopment, and growth programs, were regulated by Bcl3 over-
expression (Table 1).
Bcl3 cooperates with PGC-1 to coactivate PPAR. The
gene expression array data indicated that Bcl3 regulated a
significant subset of genes involved in cellular fatty acid oxida-
tion, many of which are known to be PPAR targets including
MCAD (Acadm) (Fig. 6), carnitine palmitoyltransferase-1a
and -1b (Cpt1a and -b), and long-chain acyl-coenzyme A syn-
thetase 1 (Acsl1) (see Tables S2 and S3 in the supplemental
material). In addition, expression of the PDK4 gene, another
known PPAR target (51) involved in the regulation of glucose
oxidation, was activated by Bcl3 (Fig. 6; see also Tables S2 and
S3 in the supplemental material). Given that PPAR is known
to be coactivated by PGC-1 (54) and that PPAR gene ex-
pression is regulated by ERR (29), we sought to determine
whether Bcl3 cooperated with PGC-1 to coactivate PPAR.
The PPAR-responsive reporter (PPRE)X3TK.Luc was co-
transfected into CV-1 cells along with various combinations of
FIG. 3. Bcl3 interacts cooperatively with PGC-1 to coactivate ERR. Results of transient transfection experiments using Vit2P36.Luc in HEK
293, mPDK4.Luc.2281, or (UAS)X3TK.Luc reporters in CV-1 cells. The reporters were cotransfected with combinations of Gal4, Gal4-ERR,
ERR, Bcl3, and PGC-1 as indicated at the bottom. The bars represent mean (
 SEM) relative light units (RLU) corrected for Renilla luciferase
activity and normalized to basal Vit2P36.Luc, mPDK4.Luc.2281, or (UAS)X3TK.Luc activity (set at 1.0). All values represent the results of a
minimum of three independent transfections conducted in triplicate. , significant difference compared to reporter activity with ERR plus Bcl3
and ERR plus PGC-1 or Gal4-ERR plus Bcl3 and Gal4-ERR plus PGC-1 (P  0.05).
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expression vectors for Bcl3, PPAR and its heterodimeric
partner, RXR, and PGC-1. Bcl3 or PGC-1 independently
boosted the PPAR/RXR-mediated regulation of the reporter
by a modest degree (approximately 2.0- to 2.5-fold), resulting
in 22-fold activation over baseline transcriptional activity (Fig.
7A). In contrast, addition of PGC-1 together with Bcl3 re-
sulted in a marked coactivation (to 80-fold) (Fig. 7A). GST
pull-down assays confirmed that Bcl3 bound directly to PPAR
and that this interaction is not influenced by addition of
ETYA, a synthetic PPAR ligand (Fig. 7B). Taken together,
these results indicate that Bcl3 and PGC-1 cooperate to co-
activate PPAR in a manner that produces effects similar to
those on ERR. This finding is notable, given the known
overlap of genes regulated by ERR and PPAR (29).
DISCUSSION
Emerging evidence indicates that an important function of
nuclear receptor coregulators is to mediate the interface be-
tween extracellular signals and gene-regulatory responses. The
PGC-1 family (PGC-1, PGC-1, and PGC-1-related coacti-
vator or PRC) fulfill this role as transcriptional coactivators
that are dynamically induced by developmental, tissue-specific,
and physiological cues to reprogram the cell to meet energy
metabolism demands imposed by diverse physiological condi-
tions such as cold exposure, exercise, and fasting (22). The
activity of the orphan nuclear receptor ERR is dependent on
coactivators such as PGC-1 to exert gene-regulatory control
of cellular energy metabolism pathways. In this study we
FIG. 4. Bcl3 interacts with PGC-1. (A) Schematic representations of PGC-1 (PGC-1Wt) and its truncation mutant (consisting of
residues 1 to 701; PGC-1701) used in GST pulldowns to localize the Bcl3 interaction with PGC-1. The gray regions represent the major
domains: the transactivating domain (TAD) and the serine/arginine-rich domain/RNA recognition motif (RS/RRM). Vertical lines L1, L2,
and L3 represent leucine-rich motifs LXXLL or LLXXL necessary for ERR binding. The numbers correspond to amino acid positions.
Bacterially expressed GST, GST-ERR, or GST-Bcl3 fusion proteins were used with 35S-labeled full-length (Wt) or truncated (701) PGC-1
in GST pull-down assays. Twenty percent of the radiolabeled proteins (20% Input) used in the binding reactions and the GST fusion proteins
with their potential binding partners were analyzed. This experiment was repeated three times, and a representative result is shown.
(B) Transient transfection experiments with Vit2P36.Luc and mPDK4.Luc.2281 were performed in HEK 293 (left) and CV-1 cells (right),
respectively. These reporters were cotransfected with combinations of ERR, Bcl3, PGC-1Wt, and PGC-1701 as indicated. The bars
represent mean (
 SEM) relative light units (RLU) corrected for Renilla luciferase activity and normalized to basal Vit2P36.Luc activity (set
at 1.0). All values represent the results of three independent transfections conducted in triplicate. , significant difference between bracketed
bars (P  0.05).
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FIG. 5. ERR/Bcl3/PGC-1 form a trimeric complex on an ERR-responsive element in cardiac myocytes. Coimmunoprecipitation experi-
ments were performed by cotransfecting combinations of Flag-ERR, PGC-1-myc, and Bcl3 in COS7 cells as indicated. Antibodies against the
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sought to identify additional coregulators of ERR and found
that Bcl3, a component of the cellular cytokine-induced in-
flammatory signaling cascade, is a potent ERR coactivator.
Our results indicate that Bcl3 interacts cooperatively with
PGC-1 to synergistically boost the activity of ERR and
PPAR, resulting in an increase in the expression of target
genes involved in cellular energy metabolism.
IB proteins regulate the Rel family of transcription factors
(p65, p50, p52, c-Rel, and RelB) (19, 21). The IB family,
which mediates key components of the cellular response to
inflammation, consists of seven members: IB, IB, IBε,
IB, p100, p105, and Bcl3 (19, 21, 23, 31, 59, 60). The best-
characterized family member, IB, sequesters the cytokine-
stimulated transcription factor, NF-B (p65/p50 heterodimer),
in the cytoplasm. Upon activation by tumor necrosis factor
alpha or other cytokines, IB is phosphorylated by IB
kinase, which leads to ubiquitination and proteasomal degra-
dation of the IB complex. Once IB is degraded, NF-B
translocates to the nucleus and initiates changes in gene ex-
pression (8, 21). Interestingly, some of the gene targets of the
NF-B pathway are members of the IB family, including Bcl3
(3, 16). Bcl3, in turn, preferentially binds to p50 and p52
homodimers, functioning as a transcriptional coactivator (1,
15). Bcl3 has also been shown to coactivate AP-1 and the
nuclear receptor RXR (38, 39). Our results demonstrate that
ERR and PPAR are also targets of Bcl3-mediated coacti-
vation.
The classical model of nuclear receptor activation involves
the exchange of coactivators for corepressors initiated by li-
gand binding to a pocket formed largely by COOH-terminal
residues, resulting in a conformational change of the COOH-
terminal AF-2 domain and realignment of helix 12, events that
are believed to be critical for nuclear receptor-coactivator sta-
bilization (42). Surprisingly, in contrast to most nuclear recep-
tor-coactivator interactions, our results indicate that binding of
Bcl3 to ERR does not require the AF-2 domain. Instead, the
Bcl3-ERR interaction requires a region adjacent to the AF-2
on the NH2-terminal side. This unusual lack of dependence on
the AF-2 region is also true of the previously defined Bcl3-
RXR interaction (38) with several notable differences. The
Bcl3-RXR interaction is influenced by the presence of 9-cis-
retinoic acid (38), whereas ligand does not appear to be nec-
essary for the Bcl3-ERR or the Bcl3-PPAR interactions. In
addition, the Bcl3-RXR interaction involves the NH2-termi-
nal ABC domain of RXR (38), whereas the Bcl3-ERR
interaction requires domains within the hinge region (between
the DNA binding domain and the ligand binding domain) and
the first two-thirds of the ligand binding domain (Fig. 2A). We
propose that the AF-2 domain-independent interaction of Bcl3
with ERR may allow for simultaneous interaction of Bcl3
with PGC-1 and perhaps other coregulators (27, 47, 58).
We found that Bcl3 and PGC-1 interact in a cooperative
manner. Mapping of this interaction revealed the surprising
finding that the Bcl3 interaction requires the COOH-terminal
96 amino acids of PGC-1, a domain that, to our knowledge,
has not previously been assigned a specific function. Again, this
interaction site may allow for PGC-1 to interact simulta-
neously with Bcl3 and nuclear receptor partners (the latter via
leucine-rich domains that exist in the amino terminal part of
the molecule). Indeed, immunoprecipitation results demon-
strate that ERR, PGC-1, and Bc13 form a complex. It is also
of interest that the TRAP/Mediator complex interacts with
PGC-1 through a domain near the Bcl3-interacting region
Flag epitope (A and B) and myc-epitope (C) were used for coimmunoprecipitation. The extracts (Input) from COS7 cells and the proteins from the
immunoprecipitations (IP) were analyzed by immunoblotting (IB) as noted. Each coimmunoprecipitation was repeated three times, and a representative
result is shown. (D) A schematic representation of the rat PDK4 promoter region is shown at the top of the panel with arrows representing primers used
for ChIP studies. PDK4P represents the region containing the ERR responsive element, and the intergenic control (IC) represents an upstream region
that does not contain any putative ERR-responsive consensus element (negative control). The numbers indicate the corresponding nucleotides. The
middle panel shows a ChIP assay performed on chromatin extracted from rat neonatal cardiac myocytes using IgG or antibodies against ERR, PGC-1,
and Bcl3 as labeled. Reimmunoprecipitation (Re-IP) was performed on chromatin immunoprecipitated by antibody against ERR and subsequently
reimmunoprecipitated using IgG or antibodies against PGC-1 and Bcl3. Crude chromatin (Input) and immunoprecipitated chromatin were analyzed
by PCR with primers (arrows) for IC, PDK4P, and rat 36B4 genome. Quantification using SYBR green real-time PCR is shown in the bottom panel. The
relative increase in enrichment represents fluorescent signal generated by PDK4P (calculated as a percentage of input) divided by fluorescent signal
generated by IC (calculated as a percentage of input and set to 1.0) for each antibody. Bars represent the mean relative increase in enrichment (
 SEM)
from three independent experiments. , significant differences between IC and PDK4P values for each antibody. (E) ChIP was performed on chromatin
extracted from rat neonatal cardiac myocytes that had been infected with adenovirus expressing siERR or its backbone control (Super) and
immunoprecipitated with IgG or antibodies against ERR, PGC-1, and Bcl3 as labeled. All analyses were as described above. , anti.
TABLE 1. Gene expression array results for Bcl3-regulated genes
in cardiac myocytesa
GO pathway No. of geneschanged
Cell cycle process.............................................................................109
Immune system process ..................................................................108
Peptidase activity .............................................................................100
Cell adhesion.................................................................................... 97
Oxidoreductase activity .................................................................. 93
Ubiquitin cycle ................................................................................. 69
Vasculature development ............................................................... 55
Generation of precursor metabolites and energy ....................... 50
Growth factor activity ..................................................................... 38
DNA replication .............................................................................. 32
Electron transport ........................................................................... 31
GTPase activity ................................................................................ 25
Cofactor metabolic process ............................................................ 19
Sphingolipid metabolic process ..................................................... 14
a Gene expression array was performed with RNA isolated from neonatal rat
cardiac myocytes after infection with either adenoviral AdGFP or AdBcl3. Data
were normalized to find the relative change in expression for each gene (AdBcl3/
AdGFP). Upregulated genes were identified with a relative change of 2-fold.
Downregulated genes were identified with a relative change of 0.5-fold. (P 
0.05; n  4). Spotfire and MAPPFinder 2 were used for analyses of gene
expression array. Of 22,280 genes, Spotfire identified 496 upregulated genes and
17 downregulated genes. MAPPFinder 2 identified changes in 266 of 6,780 gene
pathways. Boldface indicates Gene Ontology (GO) pathways involved in energy
metabolism.
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within the arginine/serine (RS) domain (55). Recently, the
interaction of PGC-1 with the transcriptional factor Yin-
Yang 1 has also been reported to occur in the COOH-terminal
half of PGC-1, but the interaction domain(s) has not been
delineated (9). Both Bcl3 and PGC-1 are coactivators without
known enzymatic activity (10, 50), i.e., class II coactivators.
Class II coactivators are thought to work by recruiting coacti-
vators with histone acetyltransferase, histone methyltrans-
ferase, or histone kinase activity, i.e., class I coactivators. It is
interesting that despite the lack of known enzymatic activity,
Bcl3 and PGC-1 act synergistically to coactivate the transcrip-
tional regulatory functions of ERR and PPAR. It is tempt-
ing to speculate that the PGC-1/Bcl3 complex recruits addi-
tional coregulators with such activity (e.g., SRC-1) with greater
efficiency and avidity than either factor alone. Interestingly,
Bcl3 has previously been reported to function with SRC-1,
which possesses histone acetyltransferase activity (38). It is also
possible that this cooperative activity is due to efficient recruit-
ment of TRAP/Mediator components that, in turn, increase
recruitment of the RNA polymerase II machinery. Lastly, our
data also cannot exclude the possibility that Bcl3 interacts with
the RNA recognition motif domain of PGC-1 because it was
also disrupted by the COOH-terminal deletion.
Bcl3 was originally discovered as a putative oncogene in-
volved in B-cell lymphocytic leukemia (41). Later, it was dis-
covered to be a regulator of the NF-B signaling cascade,
placing it within the cellular inflammatory response (57). How-
ever, in contrast to most other members of the  family, Bcl3
can localize to the nucleus, where it serves as a coactivator of
transcription factors involved in NF-B signaling. Our results
suggest that in addition to coactivating transcription factors
relevant to the NF-B pathway, Bcl3 coactivates PGC-l,
ERR, and PPAR, key regulators of cellular fuel utilization
pathways. PGC-1 is a logical Bcl3-interacting partner, given
that it is a master regulator of genes involved in energy me-
tabolism and, therefore, serves as a key nodal control point. It
is possible that this response allows the cell to adapt energet-
ically to the cellular stress of inflammation, providing bursts of
ATP production. Accordingly, this regulatory cross talk could
serve as an adaptive response to physiological stressors im-
posed on the heart. Moreover, this response is likely to be
relevant to pathological states such as cardiac hypertrophy and
ischemic insult, both of which trigger cytokine signals and
activation of the NF-B pathway (34, 35, 52).
Our gene expression array results provide additional infor-
mation about the potential biological roles of Bcl3 in cardiac
myocytes. The subset of genes we found to be activated by Bcl3
in this unbiased screen are consistent with its role as a coregu-
lator of ERR and PPAR, given that many of the activated
genes are known targets for these nuclear receptors. Specifi-
cally, pathways involved in fatty acid oxidation, electron trans-
port chain/oxidative phosphorylation, and oxidative stress re-
sponses were upregulated. However, the expression of other
genes previously reported as direct ERR targets, identified by
a combination of ChIP and genomic DNA array, or ChIP-on-
chip technique (13), were not regulated by Bcl3. Indeed, rela-
tively few genes in our data set are known ERR gene targets,
yet many of the pathways are shared. This result could reflect
differences in sensitivity and specificity between the gene ex-
pression array and ChIP-on-chip approaches, but it also raises
FIG. 6. Bcl3 induces expression of genes involved in glucose and fatty acid metabolism in rat neonatal cardiac myocytes. Graph represents mean
(
 SEM) MCAD, PDK4, FABP3, and VLDLR mRNA levels in arbitrary units (AU) after adenoviral infection of either GFP alone (AdGFP) or
Bcl3 (AdBcl3) as determined by qRT-PCR from three independent experiments. Values shown are corrected to 36B4 and normalized (1.0) to
AdGFP values. , significant difference compared to AdGFP (P  0.05).
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the intriguing possibility that Bcl3 serves as a coactivator of a
distinct subset of the PGC-1/ERR regulatory pathway, as a
unique component of the inflammatory response. The gene
expression array results also suggest that Bcl3 regulates cardiac
gene-regulatory programs involved in the immune response,
cell cycle control, and growth. Additional Bc13-regulated path-
ways of interest are those involved in peptidase activity and
ubiquitin action, given that NF-B signaling and Bcl3 have
both been implicated in muscle atrophy programs (5, 26, 37). It
will be of interest to delineate the possible role of nuclear
receptors involved in these novel pathways.
In summary, we have shown that Bcl3 is a novel nuclear
receptor coregulator that synergizes with the inducible coacti-
vator PGC-1 to drive expression of ERR and PPAR target
genes in cardiac myocytes. Given the established role of Bcl3 in
cytokine-triggered signaling, we propose that the Bcl3–
PGC-1 interaction serves as a key interface for regulatory
cross talk between inflammation and cellular energy metabo-
lism, an adaptive cardiac stress response.
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